Cargando…
A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy—Application to Nonsense Suppressor Screening and Mechanistic Studies
Premature termination codons (PTCs) account for ~12% of all human disease mutations. Translation readthrough-inducing drugs (TRIDs) are prominent among the several therapeutic approaches being used to overcome PTCs. Ataluren is the only TRID that has been approved for treating patients suffering fro...
Autores principales: | Ghelfi, Mikel D., Bhat, Saleem Y., Li, Hong, Cooperman, Barry S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953321/ https://www.ncbi.nlm.nih.gov/pubmed/36830611 http://dx.doi.org/10.3390/biom13020242 |
Ejemplares similares
-
Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms
por: Ng, Martin Y., et al.
Publicado: (2021) -
Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination
por: Huang, Shijie, et al.
Publicado: (2022) -
Rapid acanthocytic schistocytosis and fulminant microangiopathic hemolysis as a preterminal event
por: Moshref Razavi, Habib, et al.
Publicado: (2021) -
Comparison Between Terminal or Preterminal Conditioning of Donor Livers by Ex Situ Machine Perfusion
por: von Horn, Charlotte, et al.
Publicado: (2023) -
Characterization of ligand binding to dopamine receptors with fluorescence anisotropy based assay
por: Allikalt, Anni, et al.
Publicado: (2015)